At the time of writing, Pacific Biosciences of California Inc [PACB] stock is trading at $1.27, up 12.39%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling.
From an analyst’s perspective:
Pacific Biosciences of California Inc [NASDAQ: PACB] stock has seen the most recent analyst activity on November 11, 2024, when UBS downgraded its rating to a Neutral. On April 22, 2024, downgrade downgraded it’s rating to Neutral. Goldman downgraded its rating to a Neutral and decreased its price target to $2.50 on April 18, 2024. Stephens initiated its recommendation with a Overweight and recommended $11 as its price target on December 14, 2023. In a note dated December 13, 2023, Wolfe Research initiated an Peer Perform rating.
For the past year, the stock price of Pacific Biosciences of California Inc fluctuated between $1.08 and $3.70. Currently, Wall Street analysts expect the stock to reach $3 within the next 12 months. Pacific Biosciences of California Inc [NASDAQ: PACB] shares were valued at $1.27 at the most recent close of the market. An investor can expect a potential return of 136.22% based on the average PACB price forecast.
Analyzing the PACB fundamentals
According to Pacific Biosciences of California Inc [NASDAQ:PACB], the company’s sales were 154.01M for trailing twelve months, which represents an -32.79% plunge. Gross Profit Margin for this corporation currently stands at 0.2% with Operating Profit Margin at -2.66%, Pretax Profit Margin comes in at -2.01%, and Net Profit Margin reading is -2.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.25, Equity is -0.57 and Total Capital is -0.34. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.1667 points at the first support level, and at 1.0633 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.3267, and for the 2nd resistance point, it is at 1.3833.
Ratios To Look Out For
It is important to note that Pacific Biosciences of California Inc [NASDAQ:PACB] has a current ratio of 7.48. Further, the Quick Ratio stands at 6.59, while the Cash Ratio is 0.84. Considering the valuation of this stock, the price to sales ratio is 2.46, the price to book ratio is 0.74.
Transactions by insiders
Recent insider trading involved HENRY CHRISTIAN O,, that happened on Mar 03 ’25 when 12497.0 shares were sold., Van Oene Mark completed a deal on Mar 03 ’25 to sell 6486.0 shares. Meanwhile, Farmer Michele sold 2973.0 shares on Mar 03 ’25.
